Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.36
Bid: 17.52
Ask: 18.48
Change: -0.23 (-1.31%)
Spread: 0.96 (5.479%)
Open: 17.98
High: 18.00
Low: 17.36
Prev. Close: 17.59
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options and Directors' Dealings

29 Nov 2011 07:00

RNS Number : 9295S
Nanoco Group PLC
29 November 2011
 



For immediate release

29 November 2011

 

 

NANOCO GROUP PLC

("Nanoco" or "the Company")

 

Grant of Options and Director's Dealings

 

In accordance with the terms of the Company's Long Term Incentive Plan, on 25 November 2011 the Board granted a total of 4,790,000 share options in respect of its ordinary shares of 10 pence each (the "Ordinary Shares") to employees. Option grants under the Long Term Incentive Plan have been made throughout the business to align employees' interests with shareholders, to improve long term performance and to encourage staff retention.

Included within this total, the following options were awarded to Executive Directors of the Company. These options, which were granted following the recommendation of the Remuneration Committee, are subject to performance conditions and will vest over the next three years.

Director

Amount paid for grant of option

Number of options

Exercise price

Michael Edelman

Nil

500,000

50p

Nigel Pickett

Nil

500,000

50p

Colin White

Nil

500,000

50p

All other terms and conditions of these incentivisation arrangements conform with the Company's existing Long Term Incentive Plan.

Following the options granted above, the Directors' interests in the total voting rights of the Company are as detailed below:

 

Director

 

Total number of share options held

Percentage of issued share capital

Number of Ordinary Shares*

Percentage of issued share capital

Michael Edelman

989,274

0.48%

10,766,690

5.19%

Nigel Pickett

2,345,051

1.13%

10,451,931

5.04%

Colin White

768,390

0.37%

320,411

0.15%

 

* Includes jointly owned Employee Benefit Trust shares

 

 

 

For further information please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Colin White, Chief Financial Officer

Bank of America Merrill Lynch - Joint Broker

Tel: +44 (0) 20 7996 2490

Will Smith

Canaccord Genuity - Nomad and Joint Broker

Tel: +44 (0) 20 7050 6500

Simon Bridges

Cameron Duncan

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Christian Goodbody

 

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including lighting, solar cells and biological imaging. Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass. Nanoco forms strategic partnerships with major end users across a range of applications.

Nanoco was founded in 2001 and is based in Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.

For further information, please visit www.nanocotechnologies.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBBDBRGDBGBI
Date   Source Headline
8th Oct 20211:48 pmRNSNotice of Results
19th Aug 20217:00 amRNSNon-Executive Director Appointment
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.